pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·53m ago·1 min read
save

ADA internal review rejects claims of silencing protest after member expulsions

Sep 1, 2026·read at STAT ↗Neutral

An internal review by the American Diabetes Association examined the removal of five participants from its scientific sessions in New Orleans. The expulsions occurred after the individuals distributed an editorial that criticized recent federal funding cuts for diabetes research.

The five‑person committee appointed by the ADA concluded that the members were removed because their behavior violated the organization’s code of conduct, not because of the substance of the editorial. The review explicitly rejected allegations that the ADA silenced dissenting opinions.

The committee’s findings have been forwarded to the ADA board for further action, but observers expect the dispute to continue as the controversy has persisted since the June 5 incident.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: ADA review of members’ expulsion denies group censored opinions, called in police”

read at STAT ↗
512 words · retrieved 29m ago
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LEADING2National Institutes of Health
topics
Type 2 Diabetes5Cardiology4Endocrinology & Metabolism2Obesity

related stories

  • Jun 10Diabetes association leader apologizes for expulsion of members, pledges to rebuild trustSTAT
  • Jun 9Diabetes Association in uproar after members expelled from annual meeting over protest of NIH cutsSTAT
  • Aug 11Stopping statins in people over 75 at low risk for heart disease didn’t increase deathsSTAT
  • Jul 18Opinion: STAT readers on the value of primary care, obesity as a disease, and moreSTAT
  • Jul 15Deaths from coronary artery disease have fallen, but more progress is within reachSTAT